repotrectinib
Bms
['trident', 'nsclc', 'trident-1', 'sclc', 'lcsm,(-blcsm)', 'bms', 'scienceatbms']
at #asco23 we ll present results from trident-1, discussing efficacy and safety of a tyrosine kinase inhibitor in advanced ros1+ nsclc with or without central nervous system metastases. a poster presentation by will be followed by discussion &amp; q&amp;a. #lcsm 
Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below: